Operose Advisors’s Eli Lilly LLY Stock Holding History

Operose Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$787K	Sell	856 -15	-2%	-$15.2K	0.18%	64
2025 Q4	$936K	Buy	871 +17	+2%	+$16.3K	0.22%	57
2025 Q3	$652K	Buy	854 +320	+60%	+$238K	0.16%	70
2025 Q2	$416K	Hold	534	–	–	0.12%	84
2025 Q1	$441K	Hold	534	–	–	0.15%	79
2024 Q4	$412K	Hold	534	–	–	0.14%	84
2024 Q3	$473K	Hold	534	–	–	0.15%	87
2024 Q2	$483K	Buy	534 +125	+31%	+$100K	0.17%	80
2024 Q1	$318K	Hold	409	–	–	0.11%	120
2023 Q4	$238K	Sell	409 -14	-3%	-$8.17K	0.1%	100
2023 Q3	$227K	Hold	423	–	–	0.09%	109
2023 Q2	$198K	Sell	423 -22	-5%	-$9.23K	0.09%	85
2023 Q1	$153K	Hold	445	–	–	0.08%	88
2022 Q4	$163K	Sell	445 -55	-11%	-$19.5K	0.09%	79
2022 Q3	$162K	Hold	500	–	–	0.11%	69
2022 Q2	$162K	Hold	500	–	–	0.11%	69
2022 Q1	$143K	Hold	500	–	–	0.1%	81
2021 Q4	$138K	Buy	+500	New	+$127K	0.11%	82

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Operose Advisors's LLY Position: Q1 2026 in Review

Operose Advisors reduced its Eli Lilly (LLY) stake by 1.7% in Q1 2026, selling an estimated $15.2K and leaving 856 shares worth $787K. The position accounts for 0.18% of the portfolio, ranked #64.

Operose Advisors first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $936K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Operose Advisors held 856 shares of Eli Lilly worth $787K as of Q1 2026.
Operose Advisors sold 15 Eli Lilly shares in Q1 2026, an estimated $15.2K.
Eli Lilly made up 0.18% of Operose Advisors's portfolio in Q1 2026, its #64 holding.
Operose Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
Operose Advisors's Eli Lilly position peaked at $936K in Q4 2025.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Operose Advisors's 13F filing for Q1 2026, filed 12 May 2026.